NextCell Pharma
NextCell Pharma invited to present in Tokyo
Mathias Svahn will present NextCell's groundbreaking work in cell therapies and how these can contribute to sustainable and efficient healthcare solutions. The event is part of the initiative "Pioneering the Possible", where Sweden and Japan explore joint opportunities for innovation and development. NextCell's participation is funded by Vinnova, highlighting the company's role as a key player in Swedish healthcare innovation.
In addition to the presentation in Tokyo, NextCell will participate in BioJapan 2024 in Yokohama from October 9-11. There, the company will hold meetings with suppliers, service companies, and pharmaceutical firms to strengthen collaborations and business opportunities for the company's future growth.
* NextCell Pharma AB, "NextCell" or the "Company", Nasdaq First North Growth Market: NXTCL
| Datum | 2024-10-08, kl 08:45 |
| Källa | Cision |
Investera som eToros bästa investerare! Med eToros CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för funktionen.